ogalvibart (C-135-LS) - BMS
amubarvimab (BRII-196) - Brii Biosci
REGEN-COV (casirivimab/imdevimab) - Regeneron, Roche
Evusheld (cilgavimab/tixagevimab) - AstraZeneca
bamlanivimab (LY-CoV555) - Eli Lilly, AbCellera, National Institute of Allergy and Infectious Diseases
romlusevimab (BRII-198) - Brii Biosci
SAB-185 - CSL Behring, SAb Biotherap
camostat mesilate - Generic mfg.
C144-LS - BMS
interferon beta inhalation (SNG001) - Synairgen
http://clinicaltrials.gov/ct2/show/NCT04518410
 
Jul 27, 2023
 
Prev Next